| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $500K | — |
| R&D Expense | $17.8M | -15.1% |
| SG&A Expense | $23.0M | -13.0% |
| Operating Income | -$40.1M | +15.3% |
| Interest Expense | $255K | -81.4% |
| Pre-tax Income | -$41.9M | +3.2% |
| Income Tax | $0 | — |
| Net Income | -$41.9M | +3.2% |
| EPS (Basic) | -$0.05 | +16.7% |
| EPS (Diluted) | -$0.05 | +16.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.0M | -41.3% |
| Current Assets | $45.0M | -39.8% |
| Total Assets | $45.9M | -39.9% |
| Current Liabilities | $4.3M | -68.9% |
| Total Liabilities | $5.0M | -67.6% |
| Stockholders' Equity | $40.9M | -32.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.0M | +5.7% |
| Capital Expenditures | $20K | — |
| Investing Cash Flow | -$20K | +97.1% |
| Financing Cash Flow | $327K | -99.3% |
| Free Cash Flow | -$31.0M | +5.6% |